KEGG   DRUG: Vestronidase alfaHelp
Entry
D11004                      Drug                                   

Name
Vestronidase alfa (USAN/INN);
Vestronidase alfa-vjbk;
MepseVII (TN)
Product
Remark
ATC code: A16AB18
Product: D11004<US>
Efficacy
Lysosomal storage disease treatment, Enzyme replacement (beta-glucuronidase)
  Disease
Mucopolysaccharidosis VII; Sly syndrome [DS:H00132]
Comment
Enzyme replacement therapy product
Target
GUSB* [HSA_VAR:2990v1] [HSA:2990] [KO:K01195]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AB Enzymes
     A16AB18 Vestronidase alfa
      D11004  Vestronidase alfa (USAN/INN) <US>
Target-based classification of drugs [BR:br08310]
 Enzymes
  Hydrolases (EC3)
   Glycosidases
    GUSB* [HSA_VAR:2990v1]
     D11004  Vestronidase alfa (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11004
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11004
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11004
Pharmacogenomic biomarkers [br08341.html]
 Germline mutations in genetic disorder treatments
  D11004
BRITE hierarchy
Other DBs
CAS: 1638194-78-1
PubChem: 342581841
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system